Kane Biotech Inc V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc

Bullboard Posts

Comment by yellowtabon Dec 11, 2014 4:44pm

97 Views

Post# 23221260

RE:Sold half of the postion taken at .025 per share

You are smart shawshank! By insiders taking 1/2 of pp, there must be something they know that we don't. It would be so nice if Gord can tell us who he is talking to, even in general terms', it would instill confidence in the s/hs who have stood by KNE for a long long time. He knows that! Also the U.S Army thing is no longer being talked about. Are they still in the game?

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario